Stock comparison
ILLUMINA, INC. is 3.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($29.32 B vs $8.09 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ILMN is larger
ILLUMINA, INC. is 3.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($29.32 B vs $8.09 B).
Market value leader
ILMN
ILLUMINA, INC. is 3.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($29.32 B vs $8.09 B).
Revenue leader
ILMN
ILMN: $4.34B vs BIO: $2.58B.
Profit leader
ILMN
ILMN: $850.00M vs BIO: $759.90M.
Margin leader
BIO
ILMN: 19.6% vs BIO: 29.4% net margin.
| Metric | ILMN | BIO |
|---|---|---|
| Market cap | $29.32 B | $8.09 B |
| US-listed rank | #478 | #1080 |
| Revenue (latest FY) | $4.34B | $2.58B |
| Net income (latest FY) | $850.00M | $759.90M |
| Net margin | 19.6% | 29.4% |
| P/E (trailing FY) | 34.5x | 10.6x |
| SEC filings | 3,713 | 1,494 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ILLUMINA, INC. is 3.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($29.32 B vs $8.09 B).
In their latest fiscal years, ILLUMINA, INC. reported $4.34B in revenue while Bio-Rad Laboratories, Inc. reported $2.58B.
Full pages: ILLUMINA, INC. and Bio-Rad Laboratories, Inc., or browse the full rankings.